Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
8,896,104
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
362,913
-
Shares change
-
+40,282
-
Total reported value, excl. options
-
$648,980
-
Value change
-
+$64,128
-
Number of buys
-
7
-
Number of sells
-
-8
-
Price
-
$1.79
Significant Holders of BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX) as of Q3 2023
17 filings reported holding BRTX - BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value as of Q3 2023.
BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 362,913 shares
of 8,896,104 outstanding shares and own 4.08% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (137,818 shares), GEODE CAPITAL MANAGEMENT, LLC (43,278 shares), Wealth Alliance (40,000 shares), Mariner, LLC (26,668 shares), TWO SIGMA ADVISERS, LP (24,600 shares), StoneX Group Inc. (23,880 shares), STATE STREET CORP (20,459 shares), Lynwood Capital Management Inc. (20,000 shares), FNY Investment Advisers, LLC (14,665 shares), and WELLS FARGO & COMPANY/MN (9,345 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.